News
Pharmaceutical Technology on MSN23h
Epsilogen acquires TigaTx to expand pan-isotope cancer antibody pipelineUK biotech Epsilogen has acquired US-based antibody developer TigaTx in a deal that collates work from the two companies’ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback